Due to a late arrival of a contribution the Newsletter 2002 has now been
updated. See page 16 for insert.
Han
Dr. Han van de Waterbeemd
Pfizer Global Research and Development
Pharmacokinetics, Dynamics and Metabolism (PDM)
Director & Head of Drug Metabolism Technologies
IPC 351, 500/1.255
Sandwich, Kent CT13 9NJ, UK
Tel. +44-1304-646179
Fax +44-1304-656433
han_waterbeemd%a%sandwich.pfizer.com
LEGAL NOTICE
Unless expressly stated otherwise, this message is confidential and
may be privileged. It is intended for the addressee(s) only. Access to
this e-mail by anyone else is unauthorised. If you are not an
addressee, any disclosure or copying of the contents of this e-mail or
any action taken (or not taken) in reliance on it is unauthorised and
may be unlawful. If you are not an addressee, please inform the
sender immediately.
Pfizer Limited is registered in England under No. 526209 with its
registered office at Ramsgate Road, Sandwich, Kent CT13 9NJ
----------------------------------------------------------------
This message and any attachment has been virus checked by
Pfizer Corporate Information Technology, Sandwich.
----------------------------------------------------------------
Received on 2003-01-28 - 06:57 GMT
This archive was generated by hypermail 2.2.0 : 2005-11-24 - 10:21 GMT